Popular Articles
Stretch Mark Cream

Classifying Antiabortion-Rights Crimes As 'Terrorism' Unnecessary, USA Today Opinion Piece States
Scott Roeder, who is charged with the murder of abortion provider George Tiller, and James von Brunn, who is charged with last week"s shooting death of a Holocaust Memorial Museum guard, "appear to be murderers, not terrorists," Jonathan Turley, a professor of public interest law at George Washington University, writes in a USA Today opinion piece. Although "liberals denounced" the tendency of conservatives to call "every possible crime an act of terrorism" while former President George W. Bush was in office, now that there are antiabortion-rights and anti-Semetic suspects, "there is an insistence that these crimes must be treated as terrorism -- as if to call them "murder" or "hate crimes" would diminish their significance," Turley states. Many people who "kill strangers out of hate for their race or religion or some other association" are "loners or rogue operators who seek to satisfy a blood lust against different groups," Turley contends, noting that classifying a crime as an act of terrorism allows for a different types of prosecution, investigation and punishment. According to Turley, the "term "terrorism" once had a clear meaning before it was used as a point of emphasis to evaluate or distinguish certain crimes." The Bush administration"s broadening of the definition to include "any prosecution that disrupts a "potential" terrorism threat" served to further divert the term from its historical definition, he adds. Now, "many want to see terrorism investigations targeting antiabortion activists and other groups that use violent speech," Turley writes."We do not advance our efforts by classifying every hate crime as terrorism," Turley continues, adding that it would be "the terrorists who will benefit from our lack of focus" in the definition. According to Turley, the "fact is that even an authoritarian nation can do little to stop a determined rogue operator from walking into a church and killing someone like Dr. Tiller." Referring to "someone such as Roeder as a murderer does not diminish the crime or the victim" because "we do not have to call murder "terrorism" to take the crime or its causes seriously," Turley writes (Turley, USA Today, 6/17).
generic viagra online
Budget: Government Priority On Health Supported, New Zealand Medical Association
The New Zealand Medical Association (NZMA) welcomed today"s Budget which reaffirms the Government"s commitment to solving our long term health workforce problems. Drugshop to buy zoloft online and other pills.
News of the day
What Is Anal Cancer? What Causes Anal Cancer?
Anal cancer occurs in the anus, the end of the gastrointestinal tract. Anal cancer is very different from colorectal cancer, which is much more common. Anal cancer"s causes, risk factors, clinical progression, staging and treatment are all very different from colorectal cancer. Anal cancer is a lump which is created by the abnormal and uncontrolled growth of cells in the anus.
Oncology

Improvements In Diagnosis And Treatment Linked To Reduced Risk Of Death In Patients With Brain Haemorrhage

Improvements in diagnosis and treatment over the past 30 years have led to a 17% decrease in the likelihood of death from aneurysmal subarachnoid haemorrhage (the bursting of a blood vessel on the surface the brain) in the general population, according to an Article published Online First and in the July edition of The Lancet Neurology. In high-income countries aneurysmal subarachnoid haemorrhage (SAH) affects 8 in 100,000 people every year. It causes 5-10% of incident stroke cases and is associated with a poor outcome-about 30% of patients die within 24 hours and of those who survive more than a quarter are left disabled. Recent advances in diagnosis and treatments including CT and MRI techniques for detection of aneurysms, dedicated stroke units, and endovascular coiling of burst aneurysms have greatly improved the prognosis of patients who reach hospital in good condition and are suitable for these treatments. However, whether these better diagnostic and management strategies have reduced the risk of death and disability from SAH in the general population is not known. To answer this question, Dennis Nieuwkamp and colleagues from the University Medical Centre Utrecht, Netherlands, did a meta-analysis of 33 studies involving 8739 patients from 19 countries in five continents between 1973 and 2002. They adjusted the results for confounding factors such as age and sex, and also examined regional differences. Findings showed that despite an increase in the average age of patients with SAH from 52 to 62 years, over three decades the likelihood of dying from a SAH has declined from 51% to 35%-a decrease of 0.6% per year. Adjustment for sex had no effect on the reduced risk of death, and a smaller but not statistically significant decrease was shown after adjustment for age-to 0.4% per year. Interestingly, case fatality rates (proportion of people who die) in Japan were significantly lower (11.8% lower) than in Europe, USA, Australia, and New Zealand. No other regional differences in case fatality were found. The authors suggest that these regional differences may be the result of variation in the speed of patients" admission to hospital for the early occlusion of the aneurysm. The authors conclude: "In future, case-fatality after SAH might decrease even more, owing to new diagnostic and therapeutic methodsò€¦[however the focus should also be on case-morbidity]ò€¦because of the high costs from the loss of productive life-years and the long-term care of patients with SAH who become and remain disabled from a young age." In an accompanying Reflection and Reaction comment, Rustam Al-Shahi Salman and Cathie Sudlow from the University of Edinburgh highlight that two major challenges remain-aneurysm treatment in the elderly because of the aging population and the delivery of effective interventions for SAH in low to middle income countries, which bear the greatest global burden of SAH. Link to article The Lancet Neurology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):